Two years ago, Lee Fleisher and Matthew Fleisher J.D., M.P.H. founded our firm. What started as a mission to bring clinical insight to market access challenges has grown into a team with deep expertise across: ✅ Commercial strategy ✅ Patient care & quality ✅ Health policy & regulation ✅ Hospital & health systems transformation We’re proud to help our clients bring impactful technologies, therapies, and innovations to market—and we’re grateful to everyone who’s joined us on this journey. 📖 Here's a reflection from Lee on our first two years: https://lnkd.in/dNvFDkAE #healthpolicy #marketaccess #MedTech #startupmilestone #healthcareinnovation
Rubrum Advising
Business Consulting and Services
A boutique consulting firm transforming the healthcare landscape through a patient-centered, evidence-based approach.
About us
Rubrum Advising is a consulting firm established by Lee Fleisher, former Chief Medical Officer of the Center for Medicare and Medicaid Services and the Center Director for Clinical Standards and Quality, that seeks to advise and strategize with clients on matters pertaining to the adoption, diffusion and reimbursement of innovative solutions and products to improve patient outcomes and reduce total costs of healthcare within the context of regulation, safety, quality and clinical standards.
- Website
-
rubrumadvising.com
External link for Rubrum Advising
- Industry
- Business Consulting and Services
- Company size
- 2-10 employees
- Type
- Privately Held
Employees at Rubrum Advising
-
Tamara Fuller Rook
Principal | Strategic Advisor | Market Access | Health Economics | Reimbursement Policy
-
Nancy Foster
Principal, Rubrum Advising
-
Steve Hahn
CEO at Nucleus RadioPharma
-
Kurt Herzer
Bridging Healthcare, Design & Policy | Data Strategy, Evidence & Product Development | MD, PhD
Updates
-
Smarter monitoring of #AI = safer, faster #healthinnovation for patients.
Founder at Rubrum Advising | National Healthcare Leader and Clinician | Former CMS Chief Medical Officer and Director, CCSQ
#AI is reshaping #healthcare, but its uncertainty can create safety risks and regulatory challenges. A new paper from Kev Coleman at Paragon Health Institute proposes targeting post-market surveillance where unpredictability meets real patient risk, using periodic revalidation and performance monitoring and building public-private partnerships to keep costs manageable. The goal: balance #innovation with safety so lifesaving AI can reach patients faster. https://lnkd.in/evjyvBHw
-
Team #RubrumAdvising is gearing up for #MTC25 in less than two weeks. Lee Fleisher and Tamara Fuller Rook will be on site. Let us know if you'll be there! https://lnkd.in/eJ2tkeCz
-
Brain-computer interface (BCI) technologies have surgical, clinical, and commercial impacts that could rapidly improve patient care. On Oct. 3 at this year's New York Brain-Computer Interface (NYBCI) Symposium, Lee Fleisher joins a conversation with David McMullen and Leigh Hochberg to discuss clinical validation and market readiness, from early clinical trials to late-stage studies, and the scalability, safety, and ecosystem required to move #BCIs from research devices to approved products. More here: https://lnkd.in/ess2-7-m
-
Rubrum Advising reposted this
Founder at Rubrum Advising | National Healthcare Leader and Clinician | Former CMS Chief Medical Officer and Director, CCSQ
Interesting and important conversations this week on #reimbursement, clinical trials, responsible #AI, and patient empowerment at Digital Medicine Society (DiMe) Health Summit 2030. Thanks to everyone who joined our panel discussion – look forward to continuing the conversations. 📖 Learn more about the Healthcare 2030 Thesis here: https://lnkd.in/eJkqG-iv
-
-
Rubrum Advising reposted this
Tamara Syrek Jensen has spent her career shaping national coverage standards and building pathways that bring innovative technologies to patients faster. At CMS, she led reforms that modernized evidence development, created the coverage pathway for FDA breakthrough devices, and expanded access to care for millions of Medicare beneficiaries. Now at Rubrum Advising, Tamara continues to design commercialization strategies that connect policy, evidence, and payer engagement from early development through market launch. We’re honored to welcome her as keynote speaker at Innovation Summit San Diego 2025, November 19–21 at the US Grant Hotel. Don’t miss this opportunity to hear insights from one of the nation’s leading health policy voices: https://bit.ly/3K2E7zZ #InnovationSanDiego #healthpolicy #medtech #medicaldevices
-
-
Congratulations to our founder, Lee Fleisher, on his appointment to the Technology Assessment Working Group of the National Academy of Medicine's ACT-ESTI Collaborative. He’ll bring his #healthpolicy and #healthinnovation expertise to advance a biomedical innovation ecosystem that’s not only groundbreaking, but responsive to patients and society.
Founder at Rubrum Advising | National Healthcare Leader and Clinician | Former CMS Chief Medical Officer and Director, CCSQ
I’m pleased to have joined the Technology Assessment Working Group of the National Academy of Medicine ACT-ESTI Collaborative. This public-private partnership is advancing a responsible #biomedical #innovation ecosystem—ensuring science and technology respond to patient and societal needs while anticipating broader implications. Looking forward to collaborating with colleagues across clinical care, health policy, and innovation to strengthen the way we assess new technologies and ensure they deliver safe, effective, and equitable care. https://lnkd.in/eVysitFZ
-
Today we're pleased to welcome Tamara Syrek Jensen, former Director of the Centers for Medicare & Medicaid Services's Coverage and Analysis Group (CAG), as Rubrum’s Vice President of Federal Programs. A recognized leader in #healthpolicy, Tamara shaped #MedicareCoverage over more than 25 years at CMS and expanded access to diagnostics, drugs, devices, and therapies nationwide. As part of Rubrum’s work with government stakeholders, Tamara will design and execute commercialization strategies—bridging evidence planning, regulatory milestones, and payer engagement—from early development and pre-FDA authorization through full market launch. Please join us in welcoming Tamara! 🎉 🎉 More here: https://lnkd.in/eFkXvb-Y
-
-
Proud to join #MedtechVISION2025, a powerful gathering of leaders driving the future of health innovation. Many thanks to #MedTechWOMEN for convening this inspiring community!
Principal | Strategic Advisor | Market Access | Health Economics | Reimbursement Policy
Yesterday’s MedtechVISION 2025 Conference was an amazing opportunity to learn from and connect with so many impactful colleagues! Laura Findeiss #MedtechVISION2025 #MedtechWOMEN #RubrumAdvising
-
-
Trust will define the future of neurotechnology. The NeuroTrust Index is working to set clear, transparent standards that empower patients, providers, and policymakers alike. We're proud that Lee Fleisher is contributing to this global effort. If you work in health, policy, or tech, consider sharing your views before September 29. 👉 Survey link: https://lnkd.in/e5JTv5Jw #Neurotechnology #ResponsibleInnovation #FutureOfHealth
#Innovations in Healthcare #Consumers insights #Holistic market understanding #New business opportunities discovery & assessment #Strategy #Sustainability & Development
𝐂𝐚𝐥𝐥𝐢𝐧𝐠 𝐧𝐞𝐮𝐫𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐞𝐱𝐩𝐞𝐫𝐭𝐬! The World Economic Forum’s Global Future Council on Neurotechnology, in collaboration with the Cognitive Futures Lab at Duke University, is developing the #NeuroTrustIndex - a transparent framework to measure and promote responsible innovation in #neurotechnology. What is the aim of the NeuroTrust Index? A trusted reference point to: 1️⃣ Ensure transparency with clear, verifiable standards 2️⃣ Drive accountability through benchmarking and recognition 3️⃣ Empower patients, consumers, policymakers, and investors to make informed decisions How YOU can contribute: 👉 Complete our questionnaire (~15 min) via this link https://lnkd.in/e5JTv5Jw by September 29, your responses will remain confidential 👉 Share this call for feedback with your professional network to broaden perspectives Thank you for participating! Your expertise will help define how we build #trust in the future of neurotechnology. Follow this link for more on the GFC: https://lnkd.in/e2agHC2G #ResponsibleInnovation Nita Farahany Thomas Oxley Ana Maiques Anthony Costa Brett Wall Rafael Carbunaru Yotam Drechsler Tan Le Dr. Olivia Matshabane Mackenzie Weygandt Mathis, PhD David Putrino Xiaoqin Wang Maryam Shanechi Jennifer French I-han Chou Dafna Feinholz Camila Pintarelli Lee Fleisher Frédéric Destrebecq Julie Masiga-Omondi Leandro Loss, PhD